Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06422429Phase 2Not yet recruiting
Phase 2, randomised trial in obesity and Overweight (2 arms). Primary endpoints: Change in HbA1c at 6 months and Change in blood glucose at 6 months. Planned start Mar 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06422429.